• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

简化的临床管理路径可能减少慢性肢体威胁性缺血患者的大截肢:一项有历史对照的前瞻性队列研究。

Streamlined Clinical Management Pathways May Reduce Major Amputations in Patients with Chronic Limb Threatening Ischaemia: A Prospective Cohort Study with Historical Controls.

作者信息

Houghton John S M, Meffen Anna, Gray Laura J, Payne Tanya J, Haunton Victoria J, Davies Robert S M, Sayers Rob D

机构信息

Department of Cardiovascular Sciences, University of Leicester, Leicester, UK; Leicester Vascular Institute, University Hospitals of Leicester NHS Trust, Leicester, UK; National Institute for Health Research Leicester Biomedical Research Centre - The Glenfield Hospital, Leicester, UK.

Department of Cardiovascular Sciences, University of Leicester, Leicester, UK; Department of Population Health Sciences, University of Leicester, Leicester, UK.

出版信息

Eur J Vasc Endovasc Surg. 2025 Mar;69(3):465-473. doi: 10.1016/j.ejvs.2024.09.005. Epub 2024 Sep 10.

DOI:10.1016/j.ejvs.2024.09.005
PMID:39260765
Abstract

OBJECTIVE

Patient characteristics and patterns of disease in chronic limb threatening ischaemia (CLTI) have markedly changed in recent years. Urgent specialist referral and timely revascularisation are recommended in international guidelines. UK guidelines now recommend revascularisation within five days of referral for inpatients and two weeks in outpatients. This study compared the contemporary one year major amputation incidence in patients with CLTI with a historical cohort at a single UK centre.

METHODS

This was a single centre, observational cohort study with historical controls. A prospective cohort was recruited between May 2019 and March 2022. A historical cohort presenting between 2013 and 2015 inclusive was retrospectively identified. Significant changes in management pathways, including establishing a rapid access limb salvage clinic, occurred between these periods, aiming to expedite time from referral to revascularisation. The one year primary outcome was major amputation, and the secondary outcome was death. Major amputation was analysed by Fine-Gray competing risks models (death as the competing risk), presented as subdistribution hazard ratios (SHRs). One year mortality was analysed by Cox regression, presented as hazard ratios. Analyses were adjusted for propensity score.

RESULTS

A total of 928 patients were included (432 prospective and 496 historical). Proportions of patients presenting with tissue loss (72.2% vs. 71.6%; p = .090) were similar in both cohorts. At one year, 48 patients (11.1%) in the prospective cohort and 124 patients (25.0%) in the historical cohort had undergone a major amputation (p < .001). Risk of major amputation was 57.0% lower in the prospective cohort compared with the historical cohort after adjustment for propensity score (SHR 0.43, 95% confidence interval 0.29 - 0.63; p < .001).

CONCLUSION

An encouraging reduction in major amputation incidence was observed after improvements to CLTI management pathways, but residual confounding is likely. The generalisability of these results is uncertain.

摘要

目的

近年来,慢性肢体威胁性缺血(CLTI)患者的特征和疾病模式发生了显著变化。国际指南建议进行紧急专科转诊并及时进行血运重建。英国指南现建议住院患者在转诊后五天内进行血运重建,门诊患者在两周内进行。本研究比较了英国一家中心CLTI患者的当代一年期大截肢发生率与一个历史队列。

方法

这是一项采用历史对照的单中心观察性队列研究。在2019年5月至2022年3月期间招募了一个前瞻性队列。回顾性确定了一个在2013年至2015年(含)期间就诊的历史队列。在这些时期之间,管理途径发生了重大变化,包括设立了一个快速通道肢体挽救诊所,旨在加快从转诊到血运重建的时间。一年期主要结局是大截肢,次要结局是死亡。大截肢采用Fine-Gray竞争风险模型进行分析(将死亡作为竞争风险),以亚分布风险比(SHR)表示。一年期死亡率采用Cox回归分析,以风险比表示。分析对倾向得分进行了调整。

结果

共纳入928例患者(432例前瞻性患者和496例历史队列患者)。两个队列中出现组织损失的患者比例相似(72.2%对71.6%;p = 0.090)。一年时,前瞻性队列中有48例患者(11.1%)进行了大截肢,历史队列中有124例患者(25.0%)进行了大截肢(p < 0.001)。在对倾向得分进行调整后,前瞻性队列中大截肢的风险比历史队列低57.0%(SHR 0.43,95%置信区间0.29 - 0.63;p < 0.001)。

结论

在CLTI管理途径得到改善后,观察到令人鼓舞的大截肢发生率降低,但可能存在残余混杂因素。这些结果的可推广性尚不确定。

相似文献

1
Streamlined Clinical Management Pathways May Reduce Major Amputations in Patients with Chronic Limb Threatening Ischaemia: A Prospective Cohort Study with Historical Controls.简化的临床管理路径可能减少慢性肢体威胁性缺血患者的大截肢:一项有历史对照的前瞻性队列研究。
Eur J Vasc Endovasc Surg. 2025 Mar;69(3):465-473. doi: 10.1016/j.ejvs.2024.09.005. Epub 2024 Sep 10.
2
Editor's Choice - Delays to Revascularisation and Outcomes of Non-Elective Admissions for Chronic Limb Threatening Ischaemia: a UK Population Based Cohort Study.编辑推荐——慢性肢体威胁性缺血非择期入院血管再通延迟与结局:一项基于英国人群的队列研究
Eur J Vasc Endovasc Surg. 2025 Apr;69(4):640-648. doi: 10.1016/j.ejvs.2024.12.038. Epub 2024 Dec 24.
3
Vein bypass first vs. best endovascular treatment first revascularisation strategy for chronic limb-threatening ischaemia due to infra-popliteal disease: the BASIL-2 RCT.静脉旁路术优先与最佳血管内治疗优先血运重建策略治疗下肢严重缺血性疾病:BASIL-2 RCT。
Health Technol Assess. 2024 Oct;28(65):1-72. doi: 10.3310/YTFV4524.
4
Editor's Choice - Major Adverse Limb Events in Patients Undergoing Revascularisation for Lower Limb Peripheral Arterial Disease: A Nationwide Observational Study.编辑推荐——下肢外周动脉疾病血管重建患者的主要肢体不良事件:一项全国性观察性研究
Eur J Vasc Endovasc Surg. 2024 Dec;68(6):737-745. doi: 10.1016/j.ejvs.2024.07.041. Epub 2024 Aug 8.
5
Comparison of mortality and amputation after lower extremity bypass versus peripheral vascular intervention in patients with chronic limb-threatening ischemia and comorbid chronic kidney disease.比较慢性肢体威胁性缺血合并伴发慢性肾脏病患者下肢旁路与外周血管介入治疗后的死亡率和截肢率。
J Vasc Surg. 2024 Aug;80(2):480-489.e5. doi: 10.1016/j.jvs.2024.04.016. Epub 2024 Apr 10.
6
Validation of BEST-CLI among patients undergoing primary bypass or angioplasty with or without stenting for chronic limb-threatening ischemia.在接受初次搭桥或血管成形术(无论是否置入支架)治疗慢性肢体威胁性缺血的患者中对BEST-CLI进行验证。
J Vasc Surg. 2025 May;81(5):1138-1147.e2. doi: 10.1016/j.jvs.2025.01.009. Epub 2025 Jan 16.
7
Female patients have fewer limb amputations compared to male patients in the BEST-CLI trial.在BEST-CLI试验中,女性患者的肢体截肢情况比男性患者少。
J Vasc Surg. 2025 Feb;81(2):366-373.e1. doi: 10.1016/j.jvs.2024.09.031. Epub 2024 Oct 4.
8
Competing risk analysis to estimate amputation incidence and risk in lower-extremity peripheral artery disease.竞争风险分析估计下肢外周动脉疾病的截肢发病率和风险。
Vasc Med. 2024 Oct;29(5):496-506. doi: 10.1177/1358863X241268727. Epub 2024 Sep 1.
9
Impact of Bypass Conduit and Early Technical Failure on Revascularization for Chronic Limb-Threatening Ischemia.旁路血管及早期技术失败对慢性肢体威胁性缺血血管重建的影响
Circ Cardiovasc Interv. 2025 Mar;18(3):e014716. doi: 10.1161/CIRCINTERVENTIONS.124.014716. Epub 2025 Mar 18.
10
Surgery or endovascular therapy for patients with chronic limb-threatening ischemia requiring infrapopliteal interventions.慢性肢体缺血高危患者的下肢动脉腔内治疗或手术治疗。
J Vasc Surg. 2024 Nov;80(5):1515-1524. doi: 10.1016/j.jvs.2024.05.049. Epub 2024 Jun 21.

引用本文的文献

1
Regional variation in non-traumatic major lower limb amputation in England: observational study of linked primary and secondary care data.英格兰非创伤性主要下肢截肢的地区差异:基于初级和二级医疗数据关联的观察性研究
BJS Open. 2025 Mar 4;9(2). doi: 10.1093/bjsopen/zraf004.